Welcome to the eleventh issue of our report, “Mpox: Transparency and Accountability for the Global Response.”
In the wake of the U.S. health agencies’ communications and foreign aid freezes, we hope to serve as a resource for transparency on emerging outbreaks globally while continuing to provide in-depth analysis of the mpox response. We will provide brief updates on emerging outbreaks with the state of available medical countermeasures and diagnostics needed to effectively respond.
The Africa CDC is set to release the next phase of the Mpox Continental Response Plan: The incident management support team has completed the second phase of the mpox response plan which will be implemented from March 2025 to August 2025. This plan focuses on intensification, integration, and the legacy of the mpox response. The response strategy is comprised of eight domains: community-centered, multi-sectoral approach, strengthening of national and sub-national coordination, digitized surveillance, syndromic approach, decentralized laboratory testing, accelerated vaccination, and resilient health systems. Targets of this phase of the response include improving testing coverage to 80% of suspected cases, conducting genomic sequencing of 8% of confirmed cases weekly, and reaching 80% vaccination coverage of target groups (~6.4 million people total). This plan calls for a budget of USD $429,595,970 with 70% of the budget to be spent within the first 3 months (March-May). Approximately USD $196 million remains from the first phase of the response and will be available to be carried over into phase 2. Combined with approximately USD $9.6 million contributed to member states, this leaves a funding gap of USD $224 million (currently the second phase is 47.9% funded). Read more on our latest mpox and other emerging outbreaks response tracking.